Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

April
23
2026

Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026

BOCA RATON, Fla. – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for…

April
23
2026

Keloids Treatment: What Options Are Available?

For the 10 percent of the population that suffers from keloids, finding an effective treatment option can often feel like a challenge. Traditional treatment options are limited in truly removing a keloid and keeping the…

April
02
2026

Innovation, Patient Outcomes, Collaboration: Key Trends Defining Dermatology in 2026

Thousands of dermatologists and industry experts attended the 2026 American Academy of Dermatology (AAD) Conference in Denver. As with previous years, it is the premier event for defining the next chapter of the specialty –…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy